Franchise Exit Strategy: All Your Options Explained
A complete guide to franchise exit strategies — covering resale to a franchisee, corporate sale, multi-unit portfolio sale, surrender to franchisor, family succession, and partial exit options.
A complete guide to franchise exit strategies — covering resale to a franchisee, corporate sale, multi-unit portfolio sale, surrender to franchisor, family succession, and partial exit options.
When is the right time to sell a franchise business? The agreement term is the primary driver – plus market conditions, financial performance, and the renewal option decision.
A practical guide to Capital Gains Tax, Business Asset Disposal Relief (BADR), and earn-out tax treatment when selling a franchise business in the UK. Covers share vs asset sale, BADR eligibility, franchise goodwill, and key planning actions.
A guide to all dental practice exit options — DSO sale, independent sale, partial sale, associate buyout, and gradual transition. Understand what each model means for you, your team, and your practice value.
Selling an estate or letting agency is rarely a single simple transaction. There are several ways to structure an exit
A guide to the key tax considerations when selling an estate or letting agency — CGT rates, Business Asset Disposal Relief eligibility, earn-out income risk, and the share sale vs asset sale choice. Written for UK owners planning an exit.
A complete guide to the tax implications of selling a dental practice in the UK — covering Capital Gains Tax rates, Business Asset Disposal Relief (BADR), earn-outs, asset vs share sale structures, and what the April 2026 BADR rate change means for dental sellers.
A guide for estate and letting agency owners on when to sell — covering market conditions, landlord churn, compliance, lease term, owner dependency, and the optimal timing framework for a well-priced exit.
Timing is the most consequential decision in a dental practice sale. Get it right and you maximise value, complete smoothly,
Free, confidential dental practice valuation from specialist brokers. NHS goodwill multiples, private EBITDA analysis, and real UK buyer data — no obligation.